Abstract
Three new series of thiazoles, quinolones, and thiazolidinones merged with benzimidazole, benzoxazole, and benzothiazole nuclei were synthesized. The compounds were subjected to Infrared, 1H nuclear magnetic resonance, 13C nuclear magnetic resonance, mass spectrometry, and elemental analyses. Cytotoxic activity of compounds were evaluated against breast (MCF-7) and colon (HCT-116) cell lines. Seven of the compounds had IC50 values between 0.0112 and 0.0198 µM and are hence more potent than the reference drug doxorubicin (IC50 = 0.0084 and 0.0088 µM against MCF-7 and HCT-116, respectively).
Similar content being viewed by others
References
Abd Ell-All AS, Magd-El-Din AA, Ragab FAF, ElHefnawy M, Abdalla MM, Galal SA, El-Rashedy AA (2015) New benzimidazoles and their antitumor effects with aurora A kinase and KSP inhibitory activities. Arch Pharm Chem Life Sci 348:1–12
Abdelgawad MA, Belal A, Ahmed OM (2013) Synthesis, molecular docking studies and cytotoxic screening of certain novel thiazolidinone derivatives substituted with benzothiazole or benzoxazole. J Chem Pharm Res 5:318–327
Alang G, Kaur R, Singh A, Budhlakoti P, Singh A, Sanwal R (2010) Synthesis, Characterization and antifungal activity of certain (E)-1-(1-(substitutedphenyl) ethylidene)-2-(6-methylbenzo[d]thiazol-2-yl) hydrazine analogues. Int J Pharm Bio Arch 1:56–61
Amnekar N, Bhusari K (2010) Preliminary anticancer activity of some prop-2-enemido, thiazole and 1-acyl-pyrazoline derivatives of aminobenzothiazoles. Dig J Nanomat Bio 5:177–184
AsIm Z, Kaplancikli GT, Zitouni G, Revial K (2004) Synthesis and Study of Antibacterial and Antifungal Activities of Novel 2-[[(Benzoxazole/benzimidazole-2-yl)sulfanyl] acetylamino]thiazoles. Arch Pharm Res 27:1081–1085
Aurrecoechea N, Beroza PP, Damodaran KV, Pontius KY, Robinson L, Simon RJ, Vu T, Weber KT (2010) 2-[lH-benzimidazol-2(3H)-ylidene]- 2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors United States Patent Application Publication; Pub. N0.: US 2010/0081653; Pub. Date: 1 Apr. 2010
Bhuva HA, Kini SG (2010) Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors. J Mol Graph Model 29:32–37
Caleta I, Kralj M, Marjanovic M, Bertosa B, Tomic S, Pavlovic G, Pavelic K, Zamola GK (2009) Novel cyano- and amidinobenzothiazole derivatives: synthesis, antitumor evaluation, and X-ray and quantitative structure-activity relationship (QSAR) analysis. J Med Chem 52:1744–1756
Doma A, Kulkarni R, Garlapati A, Krishna PR (2014) Synthesis and anti- inflammatory activity of novel pyrimidinobenzothiazole amine derivatives. Pharmacophore 5:331–342
Franchini C, Muraglia M, Corbo F, Florio M, Mola A, Rosato A, Matucci R, Nesi M, Bambeke F, Vitali C (2009) Synthesis and biological evaluation of 2-mercapto-1,3-benzothiazole derivatives with potential antimicrobial activity. Arch Pharm Chem Life Sci 342:605–613
Gabr MT, El-Gohary NS, El-Bendary ER, El-Kerdawy MM (2014) EGFR Tyrosine kinase targeted compounds: in vitro antitumor activity and molecular modeling studies of new benzothiazole and pyrimido[2,1-b]benzothiazole derivatives. EXCLI J. 13:573–585
Gajdos P, magdolen P, Zahradnik P, Foltinova P (2009) New conjugated benzothiazole-N-oxides: Synthesis and biological activity. Molecules 14:5382–5388
Gulcan HO, Unlu SE, Banoglu MF, Sahin (2003) Synthesis of New 4-(5-Chloro-2-oxo-3H-benzoxazol-3-yl)butanamide derivatives and their analgesic and anti- inflammatory properties. Turk J Chem 27:467–476
Gullick WJ (1991) Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47:87–98
Gupta A, Rawat S (2010) Synthesis and anti-inflammatory study of novel fluoro benzothiazole derivatives. J Chemi Pharm Res 2:244–258
Havrylyuk D, Mosula L, Zimenkovsky B, Vasylenko O, Gzella A, Lesyk R (2010) Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Eur J Med Chem 45:5012–5021
Hibi S, Okamoto Y, Tagami K, Numata H, kobayashi N, Shinoda M, Kawahara T, Murakami M, Oketani K, Inoue T, Shibata H, Yamatsu I (1994) Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2- amino-6-hydroxybenzothiazole derivatives. J Med Chem 37:3062–3070
Hoi S, Park H, Lee S, Kim S, Han G, Choo H (2006) Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity. Bioorg Med Chem 14:1229–1235
Jin L, Song B, Zhang G, Xu R, Zhang S, Gao X, Hu D, Yang S (2006) Synthesis, X-ray crystallographic analysis, and antitumor activity of N-(benzothiazole-2-yl)-1-(fluorophenyl)-O,O-dialkyl-α-aminophosphonates. Bioorg Med Chem Lett 16:1537–1543
Kamal A, Reddy KS, Khan M, Shetti R, Ramaiah M, Pushpavalli SN, Srinivas C, Bhadra MP, Chourasia M, Sastry GN, Juvekar A, Zingd S, Barkume M (2010) Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole-pyrrolo[2,1-c][1,4] benzodiazepine conjugates. Bioorg Med Chem 18:4747–4761
Kandeel MM, Eman AKA, Abd El Hamid MK, Abdelgawad MA, Philoppes JN (2013) Synthesis and in vitro antitumor activity of new benzothiazole and benzoxazole derivatives. J Chem Pharm Res 5:16–21
Kaur H, Kumar S, Singh I, Saxena KK, Kumar A (2010) Synthesis, characterization and biological activity of various substituted benzothiazole derivatives. Dig J Nanomater Biostruct 5:67–76
Khattab M, Galal SA, Ragab FAF, El Diwani HI (2013) Different synthetic routes to 4-(1H-benzo[d]imidazol-2-yl)aniline. Res Chem Intermed 39:2917–2923
Kohli P, Srivastava SD, Srivastava SK (2007) Synthesis and biological activity of mercaptobenzoxazole based thiazolidinones and their arylidenes. J Chinese Chem Soc 54:1003–1010
Kricker AT, Disipio J, Stone C, Goumas JE, Armes DM, Gertig BK (2012) Armstrong, Body weight and other correlates of symptom-detected breast cancers in a population offered screening. Cancer Causes Control 23:89–102
Lipunova GN, Nosova ÉV, Mokrushina GA, Sidorova LP, Charushin VN (2000) Antitumor activity of the fluorinated derivatives of condensed quinolines and quinazolines. Pharm Chem J 34:19–22
Micael C, Zandt V, Jones M, Gunn D, Geraci L, Jones J, Sawicki D, Sredy J, Jacot J, Dicioccio AT, Petrova T, Mitschler A, Podjarny AD (2005) Discovery of 3-[(4,5,7-Trifluorobenzothiazol-2-yl)methyl]indole-N-acetic Acid (Lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. J Med Chem 48:3141–3152
Mortimer CG, Wells G, Crochard JP, Stone EL, Bradshaw TD, Stevens MFG, West well AD (2006) 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon and breast cancer cell lines. J Med Chem 49:179–185
Mosula L, Zimenkovsky B, Havrylyuk D, Vasilemissir A, Chirita IC, Lesyk R (2009) Synthesis and antitumor activity of novel 2-thioxo-4-thiazolidinones with benzothiazole moieties. FARMACIA 57:321–330
Nitta A, Fujii H, Sakami S, Nishimura Y, Ohyama T, Satoh M, Nakaki J, Satoh S, Inada C, Kozono H, Kumagai H, Shimamura M, Fukazawa T, Kawai H (2008) (3R)-3-Amino-4-(2,4,5-triluorophenyl)-N-{4-[6-(2-methoxy)benzothiazol-2-yl]tetrahydropyran -4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorg Med Chem Lett 18:5435–5438
Pardasani RT, Pardasani P, Muktawat S, Chaturvedi V (1998) Reaction of 2-thiozoline-2-thiol with isatin derivatives. Phosphorous Sulphur Silicon 142:221–227
Pareek D, Chaudhary M, Pareek PK, Ojha KG, Pareek A (2014) Synthesis and biological evaluation of substituted 3-(benzothiazolyl)-1,3-thiazolidin-4-ones. Int J Pharm Pharm Sci 6:438–455
Patel NB, Shaikh FM (2010) Synthesis of new pyridine based 4-thiazolidinones incorporated benzothiazoles and evaluation of their antimicrobial activity. J Sci 21:121–129
Prabhu PP, Panneerselvam T, Shastry CS, Sivakumar A, Pande SS (2015) Synthesis and anticancer evaluation of 2-phenyl thiaolidinone substituted 2-phenyl benzothiazole -6-carboxylic acid derivatives. J Saudi Chem Soc 19:181–185
Racane L, Kralj M, Suman L, Stojkovic R, Kulenovic VT, Zamola GK (2010) Novel amidino substituted 2-phenylbenzothiazoles: synthesis, antitumor evaluation in vitro and acute toxicity testing in vivo. Bioorg Med Chem 18:1038–1044
Ramurthy S, Aikawa M, Amiri P, Costales A, Hashash A, Jansen JM, Lin, Mab S, Renhowe PA, Shafer C, Subramanian S, Sung L, Verhagen J (2011) Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors. Bioorg Med Chem Lett 21:3286–3289
Rana A, Siddiqui N, Khan SA, Haque S, Bhat M (2008) N-{[(6-substituted-1,3-benzothiazole-2-yl)amino]carbanothioyl}-2/4-substitutedbenzamides: Synthesis and pharmacological evaluation. Eur J Med Chem 43:1114–1122
Sathe BS, Jayachandran E, Jagtap VA, Sreenivasa GM (2011) Anthelmintic activity of newly synthesized moieties of fluoro benzothiazole Schiff’s bases. Res J Pharm Bio Chem Sci 2:510–515
Seetaramswamy S, Sekar V, Gandhimathi S, Murugesan L, Perumal P (2013) Synthesis and in-vitro anticancer activity of some novel bis-benzothiazolederivatives. Int J Curr Pharm Res 5:63–64
Shi D, Bradshaw T, Wrigley S, McCall C, Lalieveld P, Fichhtner I, Stevens M (1996) Synthesis of 2-(4-aminophenyl) benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 39:3375–3384
Siddiqui N, Rana A, Khan S, Bhat M, Haque S (2007) Synthesis of benzothiazole semicarbazonnes as novel anticonvulsants- The role of hydrophobic domain. Bioorg Med Chem Lett 17:4178–4182
Siddiqui N, Rana A, Khan S, Haque S, Arshad M, Ahmed S, Ahsan W (2009) Synthesis and preliminary screening of benzothiazol-2-yl thiadiazole derivatives for anticonvulsant activity. Acta Pharm 59:441–451
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric assay for anticancer- drug screening. J Natl Cancer Inst 82:1107–1112
Surya KD, Chen LH, Stebbins JL, Machleidt T, Mehan M, Dahl R, Yuan HC, Barile E, Emdadi A, Murphy R, Pellecchia M (2009) Discovery of 2- (5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors. Bioorg Med Chem 17:2712–2717
Temiz O, Oren I, Sener E, Yalcin I, Ucarturk N (1998) Synthesis and antimicrobial activity of some novel 5 or 6 – methyl-2-(2,4-disubstituted phenyl) benzoxazole derivatives. II Farmaco 53:337–341
Tzanopoulou S, Sagnou M, Petsotas MP, Gourni E, Loudos G, Xanthopoulos S, Lafkas D, Kiaris H, Varvaigou A, Pirmettis IC, Papadopoulos M, Pelecanou M (2010) Evaluation of Re and 99mTc complexes of 2-(4’-aminophenyl) benzothiazole as potential breast cancer radiopharmaceuticals. J Med Chem 53:4633–4641
Venkatesh P, Pandeya SN (2009) Synthesis, characterization and anti-inflammatory activity of some 2-amino benzothiazole derivatives. Int J ChemTech Res 1:1354–1358
Wee XK, Yeo WK, Zhang B, TanVBC (2009) Synthesis and evaluation of functionalized isoindigo as antiproliferative agents. Bioorg Med Chem 17:7561–7562
Weng JR, Tsai CH, Omar HA, Sargeant AM, Wang D, Kulp SK, Shapiro CL, Chen CS (2009) OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt–NF-κB pathway and stress response signaling. Carcinogenesis 30:1702–1709
Acknowledgements
The authors would like to thank NMR Lab members, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt for their helping in analysing all the required samples using proton NMR and DEPT-Q techniques.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Lamie, P.F., Philoppes, J.N. Design and synthesis of three series of novel antitumor–azo derivatives. Med Chem Res 26, 1228–1240 (2017). https://doi.org/10.1007/s00044-017-1839-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-017-1839-4